A drug used to treat enlarged prostates may be a powerful medicine against Parkinson’s disease, according to an international team of scientists
Terazosin helps ease benign prostatic hyperplasia (BPH) by relaxing the muscles of the bladder and prostate.
But researchers believe it has another beneficial action, on brain cells damaged by Parkinson’s.
They say the drug might slow Parkinson’s progression - something that is not possible currently.
They studied thousands of patients with both BPH and Parkinson’s.
Their findings, published in the Journal of Clinical Investigation, suggest the alpha-blocker drug protects brain cells from destruction.
Parkinson’s is a progressive condition affecting the brain, for which there is currently no cure.